Skip to Content
Morningstar

Pacer BioThreat Strategy ETF VIRS

Morningstar Medalist Rating
Medalist Rating as of | See Pacer Investment Hub

Morningstar’s Analysis VIRS

Will VIRS outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable VIRS’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the VIRS management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of VIRS’s parent organization’s priorities and whether they’re in line with investors’ interests.

Pacer BioThreat Strategy ETF retains its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VIRS

More VIRS Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 49.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Johnson & Johnson

5.26 196,836
Healthcare

Danaher Corp

5.09 190,143
Healthcare

Walmart Inc

5.01 187,444
Consumer Defensive

Thermo Fisher Scientific Inc

4.99 186,673
Healthcare

Abbott Laboratories

4.90 183,311
Healthcare

The Home Depot Inc

4.88 182,651
Consumer Cyclical

Lowe's Companies Inc

4.85 181,477
Consumer Cyclical

Sanofi SA ADR

4.84 180,912
Healthcare

Amazon.com Inc

4.70 175,713
Consumer Cyclical

Merck & Co Inc

4.66 174,428
Healthcare